Periodically on this list the issue of immunologists advising against PICCS & Ports has come up. In the following new article, you will see that at least in terms of IVIG administration, the AAAAI Primary Immunodeficiency Committee states that "placement of indwelling catheters or ports for IGIV administration is unlikely to be beneficial." This is a Category IV recommendation, from expert committee reports or opinions or clinical experience of respected authorities.
However, it should be noted that while not as strongly based in evidence as many of the other recommendations, this statement is consistent with reported and observed behaviors and preferences re avoiding the use of long term catheters. For complete information, see the new article cited below. Marilyn Hanchett RN Director of Clinical Affairs IgG America Orange J et al. Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.J Allergy Clin Immunol. 2006 Apr;117(4 Suppl):S525-53. This message and any attachments are from IgG America and are intended only for the addressee. The message may contain privileged, confidential and/or proprietary information intended only for the person(s) named. Unauthorized forwarding, printing, copying, distribution or use of such information is strictly prohibited and may be unlawful. If you are not the addressee, please promptly delete this message and notify the sender via email of the delivery error. You may also call IgG America toll free at 877.674.9700.
